Endo Receives FDA Approval For Opana(R) ER (oxymorphone HCl) Extended-Release And Opana(R) (oxymorphone HCl) Immediate Release Tablets CII

Sat, 24 Jun 2006 11:00 AM EST

... Endo Pharmaceuticals Inc., awholly owned subsidiary of Endo Pharmaceuticals Holdings Inc. (Nasdaq:ENDP), today announced that the U.S. Food and Drug Administration (FDA) hasgranted final approval of the company's New Drug Applications (NDAs) forits extended- release and immediate-release formulations of oxymorphonehydrochloride. [click link for full article] ...